Literature DB >> 10698179

Effects of pharmacological and nonpharmacological treatments on thyroid hormone metabolism and concentrations in rat brain.

M Eravci1, G Pinna, H Meinhold, A Baumgartner.   

Abstract

The activities of the 5'I-deiodinase (5'D-I), 5'II deiodinase (5'D-II) and 5III-deiodinase (5D-III) isoenzymes and tissue concentrations of thyroxine (T4) and triiodothyronine (T3) were measured in up to 10 regions of the rat brain after acute and subchronic nonpharmacological (sleep deprivation, 12 h fasting, 14 days' calorie-reduced diet) and pharmacological (ethanol, haloperidol, clozapine, lithium, carbamazepine, desipramine, fluoxetine, tranylcypromine, and mianserin) treatments. All of these treatments induced significant and sometimes dramatic changes in 5'D-II activities and tissue concentrations of thyroid hormones and, to a lesser extent, in 5D-III activity. The activity of 5'D-I remained unaffected. The results revealed a surprising specificity for each type of treatment in terms of the isoenzyme and hormone affected, the direction of the change, the brain region affected and the time of day. The changes in thyroid hormone concentrations frequently failed to correspond in any way to those in deiodinase activities and unexpected effects such as inhibition of both 5'D-II and 5D-III were seen, indicating that there may be additional pathways of iodothyronine metabolism in the CNS. In conclusion, particularly 5'D-II activity and thyroid hormone concentrations in the CNS are highly sensitive to many different kinds of influence that may induce changes in neuronal activity. However, these changes in deiodinase activities do not ensure stable tissue concentrations of T3, but were, on the contrary, in most cases accompanied by marked changes T3 levels in the tissue. The implications of these findings for the physiological role of thyroid hormones in the CNS are discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10698179     DOI: 10.1210/endo.141.3.7358

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

Review 1.  Wnt and lithium: a common destiny in the therapy of nervous system pathologies?

Authors:  Delphine Meffre; Julien Grenier; Sophie Bernard; Françoise Courtin; Todor Dudev; Ghjuvan'Ghjacumu Shackleford; Mehrnaz Jafarian-Tehrani; Charbel Massaad
Journal:  Cell Mol Life Sci       Date:  2013-06-09       Impact factor: 9.261

Review 2.  Scope and limitations of iodothyronine deiodinases in hypothyroidism.

Authors:  Balázs Gereben; Elizabeth A McAninch; Miriam O Ribeiro; Antonio C Bianco
Journal:  Nat Rev Endocrinol       Date:  2015-09-29       Impact factor: 43.330

3.  Revisiting thyroid hormones in schizophrenia.

Authors:  Nadine Correia Santos; Patrício Costa; Dina Ruano; António Macedo; Maria João Soares; José Valente; Ana Telma Pereira; Maria Helena Azevedo; Joana Almeida Palha
Journal:  J Thyroid Res       Date:  2012-03-26

4.  Hippocampal gene expression of deiodinases 2 and 3 and effects of 3,5-diiodo-L-thyronine T2 in mouse depression paradigms.

Authors:  Natalyia Markova; Anton Chernopiatko; Careen A Schroeter; Dmitry Malin; Aslan Kubatiev; Sergey Bachurin; João Costa-Nunes; Harry M W Steinbusch; Tatyana Strekalova
Journal:  Biomed Res Int       Date:  2013-12-10       Impact factor: 3.411

5.  Thyroid Function in Pregnant Women With Moderate to Severe Alcohol Consumption Is Related to Infant Developmental Outcomes.

Authors:  Kirsten A Donald; Catherine J Wedderburn; Whitney Barnett; Nadia Hoffman; Heather J Zar; Eva E Redei; Dan J Stein
Journal:  Front Endocrinol (Lausanne)       Date:  2018-06-05       Impact factor: 5.555

6.  Pharmacological modulation of brain levels of glutamate and GABA in rats exposed to total sleep deprivation.

Authors:  Sahar Mohamed Kamal
Journal:  J Exp Pharmacol       Date:  2010-06-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.